Moreover, Yang et al. suggest that through m6A “reader” YTHDF2-mediated mRNA decay, suppressed FTO inhibits tumorgenicity as well as the expression of PD-1, and sensitizes tumor cells to anti-PD-1 blockade, which provides novel sight to reduce drug resistance [35]. This evidence concerns the gene YTHDF2 and neoplasm.